|
시장보고서
상품코드
2075817
대동맥판막 협착증 시장 : 유형별, 대동맥판 유형별, 중증도별, 최종 사용자별, 지역별Aortic Stenosis Market, By Type, By Aortic Valve Types , By Severity, By End User, By Geography |
||||||
대동맥판막 협착증 시장은 2026년에 112억 6,000만 달러 규모에 이를 것으로 추정되며, 2033년까지 229억 4,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 10.7%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 112억 6,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) : | 10.70% | 시장 규모 예측(2033년) : | 229억 4,000만 달러 |
대동맥판막 협착증이란, 좌심실과 대동맥을 가르는 대동맥판막의 개구부가 좁아지는 질환입니다. 이로 인해 심장에서 대동맥으로의 혈류가 방해받게 되며, 심장의 주요 펌프실인 좌심실이 수축할 때마다 신체로 공급되는 혈액의 양이 감소합니다. 대동맥판막 협착증은 수년에 걸쳐 서서히 진행되며, 초기 단계에서는 무증상인 경우도 있지만, 중증으로 진행될수록 증상이 나타나기 시작합니다. 심방구멍이 점점 더 좁아짐에 따라, 심장은 좁아진 개구부를 통해 충분한 혈액을 내보내기 위해 더 강하게 수축해야 하므로, 심장에 과도한 부담이 가해집니다. 치료를 받지 않을 경우, 결국 심근이 약해져 손상을 입을 가능성이 있습니다.
시장 역학
고혈압, 비만, 당뇨병 등의 위험 요인의 유병률 증가가 세계 대동맥판막 협착증 시장의 성장에 크게 기여하고 있습니다. 대동맥판막 협착증의 일반적인 원인으로는 노화, 대동맥판막에 칼슘이 침착되어 발생하는 판막 경화, 류마티스열, 그리고 대동맥판막의 선천성 기형 등이 있습니다. 고령화, 기술 발전, 그리고 인식 제고가 예측 기간 동안 전 세계 대동맥판막 협착증 시장의 성장을 견인할 것으로 전망됩니다. 또한, 의료비 증가 역시 예측 기간 동안 세계 대동맥판막 협착증 시장의 성장을 견인할 것으로 예측됩니다. 경카테터 대동맥판막 치환술(TAVR)의 보급, 새로운 치료법 및 신약 개발, 맞춤형 의료, 원격 의료 및 원격 모니터링이 예측 기간 동안 전 세계 대동맥판막 협착증 시장에 성장 기회를 가져다줄 것으로 전망됩니다.
그러나 높은 치료비, 보험 보상 정책의 제한, 이용 가능성 및 인지도와 관련된 장벽, 그리고 임상적·시술적 합병증 등이 예측 기간 동안 대동맥판막 협착증 시장의 성장을 저해할 것으로 예측됩니다.
본 조사의 주요 특징 :
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 세계 대동맥판막 협착증 시장의 주요 기업 프로파일을 소개했습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 책 '세계의 대동맥판막 협착증 시장 보고서'는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 대동맥판막 협착증 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적 및 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 대동맥판막 협착증 시장 : 유형별(2021-2033년)
제5장 세계의 대동맥판막 협착증 시장 : 대동맥판 유형별(2021-2033년)
제6장 세계의 대동맥판막 협착증 시장 : 중증도별(2021-2033년)
제7장 세계의 대동맥판막 협착증 시장 : 최종 사용자별(2021-2033년)
제8장 세계의 대동맥판막 협착증 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 섹션
AJY 26.07.09Aortic Stenosis Market is estimated to be valued at USD 11.26 Bn in 2026 and is expected to reach USD 22.94 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 11.26 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.70% | 2033 Value Projection: | USD 22.94 Bn |
Aortic stenosis is a narrowing of the aortic valve opening that divides the left ventricle from the aorta. It obstructs the blood flow from the heart into the main artery (aorta) and reduces the amount of blood pumped out to the body with each contraction of the heart's main pumping chamber. Aortic stenosis progression can occur slowly over many years and asymptomatic in early stages, with symptoms developing as it becomes more severe. As the valve opening narrows further, the heart must work harder to pump enough blood through the restricted opening, putting extra strain on the heart. This can eventually weaken and damage the heart muscle if not treated.
Market Dynamics
The rising prevalence of risk factors such as high blood pressure, obesity and diabetes is significantly contributing to the growth of the global aortic stenosis market. Some of the common causes of aortic stenosis include aging, deposits of calcium on the aortic valve which makes it stiff, rheumatic fever and congenital malformations of the aortic valve. Aging population, technological advancements, and increasing awareness are anticipated to drive growth of the global aortic stenosis market over the forecast period. Moreover, rising healthcare expenditure is also expected to boost the growth of the global aortic stenosis market over the forecast period. Transcatheter aortic valve replacement (TAVR) expansion, emerging therapies and novel drug development, personalized medicine, and telemedicine and remote monitoring are expected to create growth opportunities for the global aortic stenosis market during the forecast period.
However, high cost of treatment, limited reimbursement policies, availability and awareness barriers, and clinical and procedural complications are expected to hamper growth of the aortic stenosis market over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global aortic stenosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Braile Biomedica, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., and egnite, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global aortic stenosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic stenosis market
Aortic Stenosis Market Detailed Segmentation:
- By Type (Revenue, USD Bn, 2021 - 2033)
- Congenital Aortic Stenosis
- Acquired Aortic Stenosis
- By Aortic Valve Types (Revenue, USD Bn, 2021 - 2033)
- Mechanical Aortic Valves
- Bioprosthetic (Tissue) Aortic Valves
- By (Revenue, USD Bn, 2021 - 2033) Severity:
- Mild Aortic Stenosis
- Moderate Aortic Stenosis
- Severe Aortic Stenosis
- By (Revenue, USD Bn, 2021 - 2033) End User:
- Hospital
- Clinics
- Ambulatory Surgical Centers
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Company Profile:
- Edwards Lifesciences Corporation
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- LivaNova PLC
- CryoLife, Inc.
- Braile Biomedica
- JenaValve Technology, Inc.
- Meril Life Sciences Pvt. Ltd.
- Micro Interventional Devices, Inc.
- gnite, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Aortic Valve Types
- Market Snapshot, By Severity
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Aging Population
- High Cost of Treatment
- Transcatheter Aortic Valve Replacement (TAVR) Expansion
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- Pipeline Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Aortic Stenosis Market, By Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Congenital Aortic Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Acquired Aortic Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
5. Global Aortic Stenosis Market, By Aortic Valve Types, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Mechanical Aortic Valves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Bioprosthetic (Tissue) Aortic Valves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Global Aortic Stenosis Market, By Severity, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Mild Aortic Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Moderate Aortic Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Severe Aortic Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Global Aortic Stenosis Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
8. Global Aortic Stenosis Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022-2028
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Severity 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Lain America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Severity 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Bn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Severity 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Severity 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Severity 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Edwards Lifesciences Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- LivaNova PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CryoLife, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Braile Biomedica
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- JenaValve Technology, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Meril Life Sciences Pvt. Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Micro Interventional Devices, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- egnite, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
